Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM384579
Substrate
n/a
Meas. Tech.
Kinase Assay
IC50
14.0±n/a nM
Citation
 Altman, MDBrubaker, JDChilders, MLDonofrio, AFischmann, TGibeau, CRKattar, SDLesburg, CALim, JMaclean, JKMansoor, UFNorthrup, ABSanders, JMSmith, GF Inhibitors of IRAK4 activity US Patent  US9932350 Publication Date 4/3/2018 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM384579
Synonyms:
4-({trans-4-[3- (methylsulfonyl)pyrrolidin- 1- yl]cyclohexyl}amino) quinazoline-6-carbonitrile | US9932350, 3-13
Type:
Small organic molecule
Emp. Form.:
C20H25N5O2S
Mol. Mass.:
399.51
SMILES:
CS(=O)(=O)C1CCN(C1)[C@H]1CC[C@@H](CC1)Nc1ncnc2ccc(cc12)C#N |r,wU:12.16,wD:9.9,(2.59,5.07,;4.08,4.67,;5.56,4.27,;4.47,6.16,;3.68,3.18,;4.45,1.85,;3.68,.51,;2.14,.51,;1.37,1.85,;1.37,-.82,;-.17,-.82,;-.94,-2.15,;-.17,-3.49,;1.37,-3.49,;2.14,-2.15,;-.94,-4.82,;-2.48,-4.82,;-3.25,-6.16,;-4.79,-6.16,;-5.56,-4.82,;-4.79,-3.49,;-5.56,-2.15,;-4.79,-.82,;-3.25,-.82,;-2.48,-2.15,;-3.25,-3.49,;-2.48,.51,;-1.71,1.85,)|
Structure:
Search PDB for entries with ligand similarity: